Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
Guy Thwaites(University of Oxford), Elian Liu, Ana de Veciana(University of Oxford), Julian Sutton(University Hospital Southampton NHS Foundation Trust), Gemma Pill, Tim Planche(Leeds Teaching Hospitals NHS Trust), Sarah Wyllie(Portsmouth Hospitals NHS Trust), Janet Cairns(University College London), Alexander J. Szubert(St James's University Hospital), Martin Wiselka(University Hospitals of Leicester NHS Trust), Neil Jenkins(Heart of England NHS Foundation Trust), Achyut Guleri(Blackpool Teaching Hospitals NHS Foundation Trust), Julia Greig(Guy's and St Thomas' NHS Foundation Trust), M. Estée Török(University of Cambridge), Susan Hopkins, Denise Ward(University College London), Armando González-Ruiz(Darent Valley Hospital), Robert Tilley(National Health Service), Jane Minton(Leeds Teaching Hospitals NHS Trust), David Price(Newcastle upon Tyne Hospitals NHS Foundation Trust), A Sarah Walker(John Radcliffe Hospital), Dakshika Jeyaratnam(St George’s University Hospitals NHS Foundation Trust), Leon Peto, Martin Llewelyn(Brighton and Sussex Medical School), Luke Anson, Matthew Scarborough(University of Oxford), Fleur Hudson(Royal Free London NHS Foundation Trust), D. Ll. Griffiths, Cressida Auckland(Royal Devon & Exeter NHS Foundation Trust), Tiphanie Clarke, N Claire Gordon(University of Oxford), Jonathan D. Edgeworth(King's College London), Sarah Meisner(MRC Unit the Gambia), Gavin Barlow(University of Liverpool), Deepa Nayar(County Durham and Darlington NHS Foundation Trust), Musa Kamfose(County Durham and Darlington NHS Foundation Trust), Peter Wilson(National Health Service), John Williams(University of Cambridge), Paul Chadwick(Salford Royal NHS Foundation Trust), Pankaj Lal(University of Liverpool), Clive Graham(University of Cumbria), Laura Watson(University of Oxford), A. N. Vaughn, Emmanuel Nsutebu(Cardiff University)
Cited by 186
Related Papers
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
|The Lancet Infectious Diseases|2018|3k
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
|Nature|2021|1.3k
Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data
|medRxiv|2021|654